Alejandro Hoberman, MD

Dr. Hoberman graduated from medical school and general pediatrics residency in Buenos Aires, Argentina. He completed a General Academic Pediatrics fellowship at Children’s Hospital of Pittsburgh and joined the faculty at the University of Pittsburgh. He currently heads the Division of General Academic Pediatrics, is the Executive Vice Chair and Vice Chair for Clinical Research in the Department of Pediatrics and has been established as the Jack L. Paradise Distinguished Service Professor in honor of his research mentor. In the area of AOM, Dr. Hoberman has contributed studies to enhance prevention, diagnosis and treatment of this frequently occurring condition. In a study published in JAMA, Dr. Hoberman evaluated the efficacy of influenza vaccine in preventing AOM. He published a series of studies in the NEJM sponsored by the National Institute of Allergy and Infectious Diseases evaluating the efficacy of and adequate duration of antimicrobial therapy in young children with AOM. The study he recently reported in the NEJM was sponsored by the National Institute of Deafness and Other Communication Disorders, evaluated the efficacy of tympanostomy tubes in children with recurrent AOM and received the Clinical Research Forum Top 10 Clinical Research Achievement Award for 2022.

In the area of UTI, Dr. Hoberman evaluated prevalence, diagnosis, treatment and follow-up imaging in children. He published in the NEJM a National Institute of Diabetes and Digestive and Kidney Diseases-sponsored study evaluating the efficacy of antimicrobial prophylaxis in children with vesicoureteral reflux, and received the Clinical Research Forum Top 10 Clinical Research Achievement Award for 2015. The Pittsburgh research team recently completed two NIH-sponsored UTI clinical trials: (1) a collaboration with the University of Pennsylvania evaluating a short-course therapy for UTI in children recently published in JAMA Pediatrics, and (2) led by his colleague Dr. Nader Shaikh, a study evaluating corticosteroids in preventing renal scars in children with febrile UTI published in Pediatric Nephrology.

The quality and influence of Dr. Hoberman’s research is evident from the journals in which they are published, including the NEJM, JAMA, JAMA Pediatrics and Pediatrics. He has served on NIH special emphasis panels, FDA and NIH strategic planning workgroups, American Academy of Pediatrics guideline committees, and as a member of the Clinical Translational Science Award Child Health Oversight Committee. His research has fostered the careers of many others through his roles in fellowship training, as the chief of a large division of General Academic Pediatrics -- the recipient of the 2009 Academic Pediatric Association Outstanding Teaching Award, and in his many other collaborations. In 2014, Dr. Hoberman also received the Academic Pediatric Association Research Award that acknowledges the contribution of an individual in advancing pediatric knowledge through excellence in research, characterized by originality, creativity and methodological soundness. Dr. Hoberman also has administrative responsibilities as the President of UPMC Children’s Community Pediatrics, the largest primary care pediatrics organization in western and central PA with 58 offices including Express Care locations and over 1M yearly visits.

Professional and Scientific Society Memberships

• Argentine Pediatric Society, Fellow, 1987 
• Academic Pediatric Association, Member, 1995 
• American Academy of Pediatrics, Fellow, 1995 
• Inter-American Society of Pediatric Otolaryngology, Charter Member, 1995 
• Society for Pediatric Research, Member, 1995 
• Fellow’s Basic & Clinical Research Awards Committee, Clinical Team Member, 2007-8 
• Society for Pediatric Research, Member, 1998 
• American Pediatric Society, Member, 2007